logo

Celyad Sa (CYAD)



Trade CYAD now with
  Date
  Headline
6/10/2020 1:05:46 AM Celyad Changes Name To Celyad Oncology
6/1/2020 1:21:24 AM Celyad Announces Updates From Allogeneic Programs
3/2/2020 1:06:08 AM Celyad Names Stephen Rubino Chief Business Officer
1/13/2020 1:04:22 AM Celyad Doses First Patient With CYAD-02 In CYCLE-1 Trial For R/r AML And MDS
11/29/2019 1:06:05 AM Celyad Says Christian Homsy Steps Down From Board Of As Current CEO Filippo Petti Is Nominated Into The Role
10/2/2019 1:05:48 AM Celyad To Present Update On MCRC Clinical Program At 2019 SITC Annual Meeting
9/12/2019 9:59:02 AM Celyad Prices Offering Of 2 Mln Shares At $10.00/ADS
1/7/2019 1:03:59 AM Celyad Outlines Key 2019 Priorities Including Acceleration Of CYAD-01 Program In R/r AML And MDS
12/4/2018 1:45:22 AM Celyad Presents Update On CYAD-01 Hematological Malignancies Clinical Program At 60th ASH Annual Meeting
11/30/2018 1:01:11 AM Celyad Doses First MCRC Patient In Phase 1 AlloSHRINK Trial On Non-Gene Edited Allogeneic CAR-T Candidate, CYAD-101
11/21/2018 1:09:36 AM Celyad Announces Q3 Business Update
10/4/2018 1:02:11 AM Celyad To Present CYAD-01 Solid Tumor Clinical Updates And Pre-Clinical Pipeline Data At The 2018 SITC Annual Meeting
10/4/2018 1:01:21 AM Celyad Announces Exclusive Agreement With Horizon Discovery Group For Use Of Its ShRNA Technology
9/28/2018 1:02:12 AM Celyad Gets Transparency Notification Of Victory Capital Management